4.7 Article

Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 effect resulting from their combination

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

A Novel Chimeric Protein-based HIV-1 Fusion Inhibitor Targeting gp41 Glycoprotein with High Potency and Stability

Chungen Pan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Chemistry, Medicinal

Tricyclononene carboxamide derivatives as novel anti-HIV-1 agents

Ming-xin Dong et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Electrostatically constrained α-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide

Hiroki Nishikawa et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)

Article Microbiology

Asymmetric Deactivation of HIV-1 gp41 following Fusion Inhibitor Binding

Kristen M. Kahle et al.

PLOS PATHOGENS (2009)

Article Biochemistry & Molecular Biology

Identification of minimal sequence for HIV-1 fusion inhibitors

Hiroki Nishikawa et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Article Chemistry, Medicinal

Design of a novel HIV-1 fusion inhibitor that displays a minimal interface for binding affinity

Shinya Oishi et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Multidisciplinary Sciences

Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus

John J. Dwyer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

HIV gp41 C-terminal heptad repeat contains multifunctional domains - Relation to mechanisms of action of anti-HIV peptides

Shuwen Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Kinetic dependence to HIV-1 entry inhibition

H. Kirby Steger et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Medicine, General & Internal

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

JP Lalezari et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)